Sign in

CIK 0001070494 · Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
061376651
Phone
858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Planned sale Director sold 4,500 shares at $24.87 ($111,906)
  2. 4 Open-market sale EVP, Chief Financial Officer sold 974 shares at $25.02 ($24,369)
  3. 144 Insider Sale of Securities
  4. 4 Option exercise Director acquired 18,002 shares (option exercise)
  5. 4 Derivatives Options or other derivatives
  6. 4 Option exercise Director acquired 18,002 shares (option exercise)
  7. 4 Option exercise Director acquired 18,002 shares (option exercise)
  8. 4 Option exercise Director acquired 18,002 shares (option exercise)
  9. 4 Option exercise Director acquired 16,862 shares (option exercise)
  10. 4 Grant or award Director acquired 26,608 shares (grant or award)
  11. 8-K Event Shareholder vote results
  12. SC 13D/A Stake Beneficial Ownership Report
  13. 4 Open-market buy Director bought 896,522 shares at an average $25.33 ($22,707,098)
  14. 4 Open-market sale Principal Accounting Officer sold 5,947 shares at $22.50 ($133,808)
  15. 4 Open-market sale EVP, Chief Financial Officer sold 15,310 shares at $22.50 ($344,475)
  16. 4 Open-market sale EVP, COO, Head of Commercial sold 14,869 shares at $22.50 ($334,553)
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 12 of 70 · 1,382 filings